血液透析患者的临床管理：从药物干预到先进技术
Clinical Management of Hemodialyzed Patients: From Pharmacological Interventions to Advanced Technologies.
作者信息
Monardo Paolo, Lacquaniti Antonio
机构信息
Nephrology and Dialysis Unit, Department of Internal Medicine, Papardo Hospital, 98158 Messina, Italy.
出版信息
J Clin Med. 2022 Jul 25;11(15):4310. doi: 10.3390/jcm11154310.
Abstract
Morbidity and mortality have marginally decreased over the last 3 decades in hemodialyzed (HD) patients, despite multiple pharmacological and technological interventions [...].
摘要
在过去30年里，尽管采取了多种药物和技术干预措施，但血液透析（HD）患者的发病率和死亡率仍略有下降。
相似文献
1
Clinical Management of Hemodialyzed Patients: From Pharmacological Interventions to Advanced Technologies.血液透析患者的临床管理：从药物干预到先进技术
J Clin Med. 2022 Jul 25;11(15):4310. doi: 10.3390/jcm11154310.
2
[Effect of aging on compressive strength of lumbar trabecular bone in hemodialyzed and non-hemodialyzed patients].
Nihon Jinzo Gakkai Shi. 1994 Jun;36(6):752-61.
3
The effect of dialysis membrane type on plasma concentrations of pentosidine, a marker of carbonyl stress, in hemodialyzed patients.透析膜类型对血液透析患者血浆中戊糖苷（一种羰基应激标志物）浓度的影响。
Pol Arch Med Wewn. 2009 Oct;119(10):614-20.
4
The Mutual Contribution of 3-NT, IL-18, Albumin, and Phosphate Foreshadows Death of Hemodialyzed Patients in a 2-Year Follow-Up.3-硝基酪氨酸、白细胞介素-18、白蛋白和磷酸盐的共同作用预示着血液透析患者在两年随访中的死亡。
Antioxidants (Basel). 2022 Feb 11;11(2):355. doi: 10.3390/antiox11020355.
5
Osmolal gap in hemodialyzed uremic patients.血液透析尿毒症患者的渗透压间隙。
Artif Organs. 2012 Jan;36(1):16-20. doi: 10.1111/j.1525-1594.2011.01293.x. Epub 2011 Aug 16.
6
Abnormal calcium metabolism in hemodialyzed patients with diabetic nephropathy.
Nephron. 1984;38(1):22-5. doi: 10.1159/000183272.
7
Influence of glucose in the dialysate on the activity of erythrocyte-glutathione-peroxidase and blood selenium concentration in hemodialyzed patients.透析液中葡萄糖对血液透析患者红细胞谷胱甘肽过氧化物酶活性及血硒浓度的影响。
Arch Med Res. 2007 Apr;38(3):330-6. doi: 10.1016/j.arcmed.2006.10.012.
8
In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients.慢性尿毒症血液透析和非血液透析患者体内T细胞的预激活
Kidney Int. 1989 Oct;36(4):636-44. doi: 10.1038/ki.1989.240.
9
Oxidative stress influences CC-chemokine levels in hemodialyzed patients.氧化应激影响血液透析患者的CC趋化因子水平。
Nephron Physiol. 2004;96(4):p105-12. doi: 10.1159/000077381.
10
Relationship between body composition, sex hormones and leptinemia in hemodialyzed patients with chronic renal failure.
Clin Nephrol. 2002 Dec;58(6):431-7. doi: 10.5414/cnp58431.
引用本文的文献
1
High intradialysis diastolic blood pressure variability is an independent predictor of all-cause mortality.透析期间高舒张压变异性是全因死亡率的独立预测因素。
Ann Med. 2025 Dec;57(1):2517382. doi: 10.1080/07853890.2025.2517382. Epub 2025 Jun 17.
本文引用的文献
1
Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin.血液透析患者的免疫系统功能障碍与炎症：同一硬币的两面
J Clin Med. 2022 Jun 28;11(13):3759. doi: 10.3390/jcm11133759.
2
CKD-MBD biomarkers and CKD progression: an analysis by the joint model.慢性肾脏病-矿物质和骨异常生物标志物与慢性肾脏病进展：联合模型分析
Nephrol Dial Transplant. 2023 Mar 31;38(4):932-938. doi: 10.1093/ndt/gfac212.
3
Clinical performance, intermediate and long-term outcomes of high-volume hemodiafiltration in patients with kidney failure.大容量血液透析滤过治疗肾衰竭患者的临床疗效、中期和长期结局。
Semin Dial. 2022 Sep;35(5):420-426. doi: 10.1111/sdi.13105. Epub 2022 Jun 11.
4
Low Parathyroid Hormone Secondary Hyperparathyroidism and Survival in Patients Undergoing Hemodialysis: A Propensity-Matched Analysis.低甲状旁腺激素、继发性甲状旁腺功能亢进症与血液透析患者生存：倾向评分匹配分析。
Front Endocrinol (Lausanne). 2022 May 13;13:869330. doi: 10.3389/fendo.2022.869330. eCollection 2022.
5
Randomized comparison of three high-flux dialyzers during high-volume online hemodiafiltration-the comPERFORM study.高通量在线血液透析滤过期间三种高通量透析器的随机对照研究——comPERFORM研究
Clin Kidney J. 2021 Oct 5;15(4):672-680. doi: 10.1093/ckj/sfab196. eCollection 2022 Apr.
6
Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical Setting.在意大利临床环境中对拟钙剂治疗慢性肾脏病继发性甲状旁腺功能亢进的真实世界评估。
Healthcare (Basel). 2022 Apr 11;10(4):709. doi: 10.3390/healthcare10040709.
7
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.罗沙司他对比促红细胞生成素α治疗透析患者慢性肾脏病相关贫血的随机 3 期 ROCKIES 研究结果。
J Am Soc Nephrol. 2022 Apr;33(4):850-866. doi: 10.1681/ASN.2020111638.
8
The Search for the Perfect Agent for Anemia Management in Chronic Kidney Disease.寻找慢性肾脏病贫血管理的理想药物
J Am Soc Nephrol. 2022 Apr;33(4):662-664. doi: 10.1681/ASN.2022020173.
9
The Next Evolution of HemoDialysis eXpanded: From a Delphi Questionnaire-Based Approach to the Real Life of Italian Dialysis Units.血液透析扩展的下一步发展：从基于德尔菲问卷调查法到意大利透析单位的实际情况。
Blood Purif. 2022;51(11):943-952. doi: 10.1159/000522038. Epub 2022 Mar 1.
10
Detecting and Treating Lung Congestion with Kidney Failure.检测和治疗伴有肾衰竭的肺部淤血。
Clin J Am Soc Nephrol. 2022 May;17(5):757-765. doi: 10.2215/CJN.14591121. Epub 2022 Feb 9.
Zotero 插件